Breaking and Making Tolerance: The PD-1/PD-L1 Axis in Lupus Nephritis

Area of Science:

• Immunology
• Nephrology
• Translational Medicine

Background:

• The PD-1/PD-L1 axis is a critical immune checkpoint typically maintaining tolerance.
• In lupus nephritis (LN), this pathway was considered protective, supported by mouse models.
• However, expanded PD-1⁺ T cells in LN patients correlate with disease severity, presenting a paradox.

Purpose of the Study:

• To reconcile the dual roles of PD-1/PD-L1 signaling in LN.
• To propose a "signal balance model" for precision immunomodulation in LN.

Main Methods:

• Analysis of PD-1⁺ T cell phenotypes (effector, Tph, Tfh) in LN patients.
• Investigation of factors influencing PD-1/PD-L1 signaling (cytokines, costimulation, reverse signaling).
• Review of existing and potential therapeutic strategies targeting the PD-1/PD-L1 axis.

Main Results:

• Expanded PD-1⁺ T cells in LN exhibit effector functions, driving tissue injury and autoantibody production.
• PD-1/PD-L1 signaling complexity arises from T cell heterogeneity and inflammatory signals.
• The net effect of PD-1/PD-L1 signaling depends on multiple interacting determinants.

Conclusions:

• A "signal balance model" is proposed to explain the paradoxical roles of PD-1/PD-L1 in LN.
• This framework supports patient stratification and biomarker development for tailored LN therapies.
• Targeting the PD-1/PD-L1 axis requires nuanced strategies beyond uniform immunosuppression.